LARC Medicare update 

Dear Doctor Hoang Huynh,
On the 13th of November we sent you an update on changes to MBS item fees for the
insertion and removal of long-acting reversible contraceptives (LARC).
The details we listed may not have been clear in relation to the increased schedule fee
and benefit.
We wish to clarify that the schedule fee and benefit for the following four existing MBS
items have now been increased to:
Insertion of an IUD (item 35503)
Amended Fee: $215.95
Benefit: 75% = $162.00 85% = $183.60
Removal of an IUD under general anaesthesia (item 35506)
Amended Fee: $134.45
Benefit: 75% = $100.85
Implantation of hormonal implants (item 14206)
Amended Fee: $100.40
Benefit: 75% = $75.30 85% = $85.35
Removal of Implanon (etonogestrel) (item 30062)
Amended Fee: $105.15
Benefit: 75% = $78.90 85% = $89.40

For further information, click here to see the MBS online fact sheet: New and amended
items for long-acting reversible contraceptives (LARC)
The need for more affordable and accessible LARC services
The Contraceptive CHOICE Project, one of the largest prospective cohort studies of women in
the USA (n=9256), showed:2,3
Women prefer the least user-dependent methods: When barriers of cost, knowledge,
and access were removed, 75% of women chose a LARC method.2,3
LARC uptake impacts unintended pregnancy rates: Non-LARC users were 22 times
more likely to experience an unintended pregnancy compared to their LARC
counterparts.2
Why consider a hormonal IUS?
Mirena®4 Kyleena®4,5
Contraception: Up to 8 years Contraception: Up to 5 years
Idiopathic menorrhagia: Up to 5 years.
If symptoms do not return, the system
can remain in place for up to 8 years
Smallest IUS available in Australia
Prevention of endometrial hyperplasia
during estrogen replacement therapy:
Up to 5 years
Low hormone dose: Low systemic daily
dose due to local administration
Mirena®
effectiveness4,6
Typical use: 99.8%
Perfect use: 99.8%
Based on % of women with an unintended
pregnancy at 1 year
Pill effectiveness6
Typical use: 91%
Perfect use: 99.7%
Based on % of women with an unintended
pregnancy at 1 year and on combined pill and
progestin only pill data
Typical use = incorrect or inconsistent use eg. delayed injection or forgetting to take the pill. Perfect use = correct and consistent use.6

RESOURCES FOR YOU AND
YOUR PRACTICE
To access and request available materials, click
here for the Material Request Form
Thank you for your commitment to women's health.
Best regards,
Juliana Fonseca
Brand Manager, Women’s Health
womenshealthcare.au@bayer.com
PBS Information:
Kyleena: Restricted Benefit. Contraception.
Mirena: Restricted Benefit. Contraception. Idiopathic menorrhagia where oral therapies are ineffective
or contraindicated.